Estrella Immunopharma Inc. (ESLA) — Tangible Net Worth Ratio
Estrella Immunopharma Inc. (ESLA) has a Tangible Net Worth Ratio of 100.0% as of December 2024. This metric is calculated by deducting intangible assets ($0.00) from net assets ($143.73K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Estrella Immunopharma Inc. (ESLA) net assets for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Estrella Immunopharma Inc. Tangible Net Worth Ratio (2022–2024)
This chart shows how Estrella Immunopharma Inc.'s Tangible Net Worth Ratio has changed across 3 annual periods from 2022 to 2024. As of December 2024, the ratio stands at 100.0%, reflecting net assets of $143.73K with intangible assets of $0.00 USD. Also explore net asset momentum of Estrella Immunopharma Inc. to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Estrella Immunopharma Inc. (2022–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Estrella Immunopharma Inc. from 2022 to 2024, covering 3 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see ESLA market cap overview.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | $143.73K | $0.00 | $3.14 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $4.27 Million | $0.00 | $4.45 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $7.07 Million | $0.00 | $9.99 Million | — |